Literature DB >> 12519380

After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments.

A Zandvoort1, M E Lodewijk, P A Klok, M A Breukels, G T Rijkers, W Timens.   

Abstract

Chemotherapy has, besides the beneficial effects, several adverse effects. Suppression of the immune system is one of the most important problems. Infections caused by encapsulated bacteria like Streptococcus pneumoniae are responsible for a major part of infectious problems during and after treatment. The splenic marginal zone is essential in the initiation of an immune response to encapsulated bacteria. In this study, we analysed the effects of three different cytostatic agents on humoral immune responses. We found a reduced, but detectable immune response capacity at two days after treatment although the marginal zone B cell population is severely reduced at this time point. Twenty-four days after cessation of treatment, the immune response capacity was largely restored although lymphoid compartments were still not completely restored at that time point. Apparently, the presence of only few marginal zone B cells is sufficient to evoke a rise in antibody titres and although antibody titre increases are low, even small rises are most likely clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519380      PMCID: PMC1808606          DOI: 10.1046/j.1365-2249.2003.02044.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

Review 2.  The prevention of pneumococcal disease by vaccines: promises and challenges.

Authors:  G A Poland
Journal:  Infect Dis Clin North Am       Date:  2001-03       Impact factor: 5.982

3.  Bacterial infections in pediatric Hodgkin's disease: relationship to radiotherapy, chemotherapy and splenectomy.

Authors:  S S Donaldson; E Glatstein; K L Vosti
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

4.  Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.

Authors:  R S Speirs; R W Benson; B J Knowles; D Roberts
Journal:  J Environ Pathol Toxicol       Date:  1978 Jul-Aug

5.  Pneumococcal polysaccharide immunization in infants and children.

Authors:  M J Cowan; A J Ammann; D W Wara; V M Howie; L Schultz; N Doyle; M Kaplan
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

6.  Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine.

Authors:  R Leemans; G Harms; G T Rijkers; W Timens
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

7.  Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides.

Authors:  M A Breukels; A Zandvoort; G P van Den Dobbelsteen; A van Den Muijsenberg; M E Lodewijk; M Beurret; P A Klok; W Timens; G T Rijkers
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

9.  Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens.

Authors:  B Bonavida; I V Hutchinson; A Thomas
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

10.  Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).

Authors:  H F Havas; G Schiffman
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

View more
  1 in total

1.  Immunologic consequences of chemotherapy for acute myeloid leukemia.

Authors:  Anne Reilly; Leslie S Kersun; Eline Luning Prak; Jean Boyer; Kenyetta McDonald; Abbas F Jawad; Kathleen E Sullivan
Journal:  J Pediatr Hematol Oncol       Date:  2013-01       Impact factor: 1.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.